Chi-Jen Chu, Shou-Dong Lee. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Alanine Transaminase/bloodAntiviral Agents/therapeutic useBiomarkers/bloodDNA, Viral/bloodDrug Therapy, CombinationHepacivirus/geneticsHepacivirus/immunologyHepatitis B/complicationsHepatitis B/diagnosisHepatitis B/drug therapyHepatitis B Surface Antigens/bloodHepatitis B virus/geneticsHepatitis B virus/immunologyHepatitis C Antibodies/bloodHepatitis C, Chronic/complicationsHepatitis C, Chronic/diagnosisHepatitis C, Chronic/drug therapyHumansInterferon alpha-2Interferon-alpha/therapeutic usePolyethylene Glycols/therapeutic useRNA, Viral/bloodRecombinant ProteinsRibavirin/therapeutic useTreatment Outcome
Substances： See more » Antiviral AgentsBiomarkersDNA, ViralHepatitis B Surface AntigensHepatitis C AntibodiesInterferon alpha-2Interferon-alphaRNA, ViralRecombinant ProteinsPolyethylene GlycolsRibavirinAlanine Transaminasepeginterferon alfa-2bpeginterferon alfa-2a
Year: 2010 PMID： 20136983 DOI： 10.1111/j.1440-1746.2009.06134.x
Source DB: PubMed Journal: J Gastroenterol Hepatol ISSN： 0815-9319 Impact factor: 4.029